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Abstract
In China, KSHV seroprevalence varies considerably among different regions and ethnicities. But in Xinjiang province, located in the
northwestern China, there is a very high seroprevalence of KSHV in adults of Kazak and Ughur ethnicities. However, KSHV prevalence in
children and the risk factors associated with the acquisition of infection are currently not known. The aim of this study was to investigate the
prevalence of KSHV infection and identify associated socioeconomic or behavioural risk factors and the humoral immune response among
children in this population. This is a cross-sectional study (N = 178) to screen children and their caregivers from Xinjiang for total KSHV
antibodies, KSHV neutralizing antibodies and HIV infection. Structured questionnaires were utilized to investigate risk factors associated
with KSHV prevalence. KSHV seroprevalence in children and caregivers in Xinjiang was 48.3% and 64.7%, respectively. Neutralizing antibody
was detected in most seropositive caregivers (93.8%) but was detected in only 5.8% of the infected children. A signiﬁcant association was
observed between child KSHV seroprevalence and sharing of food among family members. These results suggest that similar to other
endemic areas in Africa, KSHV infection in the minority populations of Xinjiang is likely to be occurring during early childhood, probably via
horizontal transmission through saliva, and results in high seroprevalence in the adult population.
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Introduction
Kaposi sarcoma (KS)-associated herpesvirus (KSHV), or
Human herpesvirus 8 (HHV8), is the aetiological agent
associated with KS [1,2]. Global seroprevalence of KSHV
varies in different geographical regions. It is generally low to
moderate in Western countries (3–23%) but endemic in the
general population (>50%) in sub-Saharan Africa and even
higher in HIV-positive individuals [3–5].
As in most Asian countries [6], the incidence of KS and
seroprevalence of KSHV is low in most provinces of China
(7.3–16.1% in adults) [7–10]. Xinjiang province, situated in
northwestern China, has a signiﬁcantly higher incidence of KS
(classic and AIDS-associated) and a higher seroprevalence of
KSHV in adults [11]. The higher prevalence could be associ-
ated with the ethnic makeup of the population. In mainland
China, Han is the major ethnic group but in Xinjiang, other
ethnicities such as Uygur, Kazaks and Hui are in the majority
[10,11]. Studies conducted in the Uygur and Kazak ethnic
groups have reported KSHV seroprevalence in adults to be as
high as 46.6% [10–12]. Interestingly, Xinjiang also has one of
the highest prevalences of HIV infection in China, especially
among injection drug users, in whom prevalence can be as high
as 80% [13,14].
The exact routes of KSHV transmission are unclear and may
differ by geographical region and risk group. Sexual transmis-
sion, organ transplant and blood transfusion in adults have
been reported [15–18]. Saliva is considered to be the major
route of transmission from infected adults to children in sub-
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Saharan Africa, and early childhood infection could be
contributing to the high prevalence of KSHV in the adult
population [19,20]. The unique lifestyle and culture of the
Uyghurs and the Kazakh ethnic groups in Xinjiang could
facilitate salivary contact and thereby enhance early childhood
KSHV infection, and subsequently high prevalence in the
population, as seen in KS endemic regions.
Most reports published so far have investigated prevalence
and risk factors in adults and not much is known about the
prevalence and risk of KSHV infection in children in the
Xinjiang region. We hypothesize that early childhood infection
in Xinjiang is common and contributes to the high prevalence
of KSHV in the population. Therefore, the goal of the current
study is to investigate the serological proﬁle of and immune
response to KSHV in children and their caregivers, and
determine the risk factors that may be associated with KSHV
prevalence in children.
Material and Methods
Study cohort
Between March and October 2011, caregivers having children
between 6 and 60 months of age, attending local clinics in
Xinyuan and Jiashi Counties in Xinjiang province, were
approached to participate in this study. Children over
6 months of age were recruited to avoid the detection of
transplacental maternal antibodies. Recruitment occurred
from at least three clinics representing different regions of
the county to ensure random distribution of the study subjects
and reﬂect the general population of the region, where the
majority is of Uygur or Kazakh ethnicity. The caregivers were
educated about the study and signed informed consent was
obtained. This study was approved by the institutional review
boards at the University of Nebraska and Hangzhou Normal
University.
Sample collection
Blood samples were collected in EDTA tubes from children
and their caregivers and plasma was separated. Specimens
collected from children and caregivers were coded by a unique
identiﬁcation number. All specimens were stored at 70°C
until testing.
Data collection
A standardized format was used to collect information on
study participants and the data included socioeconomic
status, home living conditions, lifestyle risk factors and child
care. A trained interviewer conducted ﬁeld-based intake
interviews with the child’s primary caregiver. Data collection
instruments that were used in the study represent modiﬁed
versions of the data forms used by our ongoing household
study in Zambia, but were ﬁeld tested and adapted to the
local setting [21].
Serological testing
KSHV serological test. All plasma samples were tested using a
monoclonal-enhanced immunoﬂuorescence assay (mIFAs) as
previously described [22]. Brieﬂy, BC3 cells were stimulated
with tetradecanoyl phorbol acetate (TPA), then ﬁxed with 4%
paraformaldehyde and incubated with patient plasma. The
signal was enhanced using murine monoclonal anti-human
immunoglobulin and then incubated with ﬂuorescein-isothio-
cyanate conjugated anti-mouse antibody. Slides were read
independently by two experienced laboratory workers. All
positive plasmas were diluted further and tested by mIFA to
estimate the KSHV antibody titre of each sample.
HIV-1 test. All plasma samples were tested by a standard HIV-1
test kit (1 + 2 type antibody diagnostic kits, Beijing Wantai
Biological Pharmacy Enterprise Company, Beijing, China) and
conﬁrmed by a second kit (Colloidal Gold Device, Beijing
Wantai Biological Pharmacy Enterprise Company).
KSHV neutralization assay. Neutralizing antibodies against
KSHV were detected for all seropositive children and care-
givers by a ﬂow cytometry-based neutralization assay, as
described earlier with minor modiﬁcations [23]. Plasma was
diluted and mixed with recombinant KSHV expressing GFP
(rKSHV.219) and incubated for 1 h at 37°C. The virus and
plasma mixture was added to a 96-well plate seeded with 293
cells. After incubation for 72 h, green cells were counted by
ﬂow cytometry. Results were conﬁrmed by counting at least
100 cells under a ﬂuorescence microscope. A positive
neutralizing antibody outcome was deﬁned as ≥50% reduction
in infectivity as compared with the sero-negative control
serum. Positive plasma samples were diluted further to
determine the neutralizing antibody titre.
Statistical analysis
All data were analysed using the statistical software packages,
SPSS version 17 (SPSS, Chicago, IL, USA) and SAS v9.2 (SAS
Institute, Cary, NC, USA). Descriptive analyses and distribu-
tion of all key variables were conducted. Risk factor analysis
was conducted using logistic regression. Multivariable analysis
included all variables that had a p-value ≤0.20 to control for
possible confounders and identify independent associations.
We also checked the correlation between all variables to
identify interactions and multi-collinearity. Correlation analysis
was evaluated by Pearson’s correlation coefﬁcient.
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Results
Study participants
A total of 178 children and 150 caregivers (15 caregivers had
two children, 13 caregiver samples had insufﬁcient volume for
laboratory testing) were recruited to participate in the study.
Table 1 summarizes the characteristics of the study cohort
and the unadjusted odds ratio for the child who was KSHV
seropositive. Brieﬂy, only seven participants were of Han
ethnicity, the rest (171 children) belonged to an ethnic
minority. All the participants were recruited from either Jiashi
(89.9%) or Xinyuan counties (10.1%). None of the demo-
graphic characteristics were associated with an increased risk
of KSHV in children.
KSHV seroprevalence and antibody titres
The overall seroprevalence of KSHV among children in this
cohort was 48.3% and was signiﬁcantly higher among caregiv-
ers (64.7%) (Fig. 1a). The endpoint titre of all KSHV-positive
children’s and caregiver’s plasma was determined, and we
observed that the geometric mean titre (GMT) of caregivers
was signiﬁcantly higher than that of the children (p 0.002)
(Fig. 1b). Also, the interquartile (IQR) range was wider for the
caregivers. As the antibody titre in caregivers is signiﬁcantly
higher, we hypothesized that KSHV titres could correlate with
age. The scatter plots in Fig. 2 show that there was no
signiﬁcant relationship between age and KSHV titres for
caregivers (correlation coefﬁcient = 0.14) (Fig. 2a) and chil-
dren (correlation coefﬁcient = 0.09) (Fig. 2b).
KSHV neutralizing antibody prevalence and titres
Given the high prevalence of KSHV infection in both children and
caregivers, and high KSHV antibody titres in caregivers, we
investigated the prevalence of neutralizing antibodies in KSHV-
positive participants. We found that 91/97 seropositive care-
givers (93.8%) had detectable levels of neutralizing antibodies. In
contrast, only 4/86 (4.7%) KSHV-seropositive children had
detectable neutralizing antibody. Even though there was a small
number of children with detectable neutralizing antibody
response, we further investigated whether there was a signif-
icant difference between neutralizing antibody titres for children
and those for caregivers (data not shown). Further, we also
investigated whether there was a correlation between neutral-
izing antibody titres and KSHV antibody titres in both caregivers
and children. Figure 2(c) shows the scatter plot of KSHV
antibody titres against neutralizing antibody titres for caregivers
and children; we did not ﬁnd a strong positive correlation
between them (correlation coefﬁcient = 0.10).
Risk factors associated with KSHV prevalence
To analyse whether any behaviour risk factors could have
contributed to the high KSHV seroprevalence in the children
in this study cohort, a wide range of data pertaining to
socioeconomic status, household living conditions and various
behavioral risks factors was collected. We speciﬁcally focused
on factors that may contribute to horizontal transmission of
KSHV to children. Tables 1 and 2 summarize the results of
univariate analysis to investigate the association between
KSHV prevalence and various risk factors. None of the
socioeconomic status factors such as living conditions and
dwellings was found to be associated with KSHV infection of
the children in the household. Other factors involving the
child’s hygiene and interactions with other children and family
members were also not found to be signiﬁcant.
Because saliva has been implicated as a major source of
early childhood infection in KSHV endemic regions, a number
of risk factors associated with feeding habits, including those
that may involve saliva exchange between household members
and the children, were analysed. The only risk factor that was
TABLE 1. Characteristics of the
study population and KSHV sero-
prevalence in Xinjiang, China
Characteristic N (%)
Child KSHV
Number positive (%) Unadjusted odds ratio p-value
Ethnicity
Han 7 (3.9) 1 (14.3)
Minority 171 (96.1) 85 (49.7) ND
County of residence
Jiashi 160 (89.9) 80 (50.0) 2.00 (0.72–5.59) 0.19
Xinyuan 18 (10.1) 6 (33.3) 1.00
Gender
Male 108 (60.7) 47 (43.5) 0.61 (0.33–1.12) 0.11
Female 70 (39.3) 39 (48.3) 1.00
Child age, median (range) 3.5 (0.6–5.5) 86 (48.3) 1.16 (0.90–1.50) 0.27
Caregiver HIV positive 2 (1.3) ND
Caregiver education
No schooling 5 (50) 1.41 (0.38–5.33) 0.61
Primary school 51 (53.1) 1.60 (0.86–2.98) 0.14
Junior school and beyond 29 (41.4) 1.00
Total 178 86 (48.3)
ND, not done.
The number of HIV-positive caregivers was too small for reliable statistical analysis.
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signiﬁcantly associated with KSHV infection in the children was
the sharing of food with family members (OR = 2.48, 95%
conﬁdence interval (CI) = 1.36–4.54, p 0.003). None of the
other feeding practices has a signiﬁcant association with KSHV
infection in children.
A multivariate analysis was carried out to further identify
independent risk factors for KSHV infection after controlling for
potential confounding factors (Table 3). Sharing food between
the child and family members remained signiﬁcant in a multivar-
iate model after adjusting for gender, ethnicity of children, per
capita living space, occupation and the number of rooms in the
house (OR = 2.19, 95% CI = 1.17–4.13, p 0.015).
Discussion
This is the ﬁrst study conducted among children in Xinjiang, an
autonomous region in northwestern China, to determine the
humoral immune response against KSHV and identify risk
factors associated with KSHV prevalence. Xinjiang has a unique
mix of various ethnicities and has been reported to be an
endemic area for KS and KSHV infection. More than 95% of KS
cases were observed in minority groups, particularly in Uygurs
[24]. Several studies have investigated KSHV seroprevalence in
adults. However, none have investigated the seroprevalence of
KSHV and the prevalence of neutralizing antibodies in children
or identiﬁed risk factors associated with KSHV seroprevalence
in children.
In this study, we observed high KSHV seroprevalence in
children (48.3%), supporting our hypothesis that KSHV infec-
tion occurs in early childhood, which may contribute to high
KSHV prevalence in the adult population. We have observed
similarly high KSHV prevalence in Zambia, another endemic
area for KSHV infection [25]. As also shown by other studies,
we observed a high prevalence of KSHV in adult caregivers
(64.7%) in this population, demonstrating that Xinjiang is a
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FIG. 1. (a) Prevalence of KSHV infection in children and caregivers. (b) Comparison of KSHV antibody titres in children and caregivers in the study
population in Xinjiang, China.
(a) (b) (c)
FIG. 2. Scatter plot to demonstrate the correlation between KSHV antibody titre and age in (a) caregivers and (b) children. (c) Scatter plot to
demonstrate the correlation between KSHV antibody titre and neutralizing antibody titres in caregivers and children in the study population in
Xinjiang, China.
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unique region where KSHV infection is signiﬁcantly higher than
in other provinces in China [7,10]. The high prevalence of KSHV
and high KSHV antibody titres in adults are likely to lead to
transmission of KSHV to children. Therefore, we were
interested in identifying speciﬁc child-rearing behaviours that
may be associated with transmission. No study to date has
examined the association of KSHV infection in children with
common child-rearing behaviours, socioeconomic indicators,
breastfeeding and other child hygiene practices in China. In this
study we did not ﬁnd any signiﬁcant association between KSHV
infection of children and various demographic and socioeco-
nomic indicators. We observed that sharing food with family
members was highly associated with KSHV seropositivity in
children, indicating that horizontal transmission via saliva could
be an important factor in early childhood infection. This is
consistent with our previous ﬁndings that KSHV DNA can be
easily detected in the saliva of infected individuals and more
frequently in those who had higher KSHV antibody titres
[20,26–28]. We did not ﬁnd an increased risk of KSHV
seropositivity in breastfed children. These results are also
consistent with our previous study in Zambian children, where
we observed that KSHV cannot by readily detected in and
transmitted via breast milk [20].
The observed high seroprevalence among caregivers seems
to be higher than other studies and could be attributed to
differences in study populations. Also, most KSHV assays differ
in their sensitivity and speciﬁcity to detect KSHV antibodies.
We chose to conduct IFA to screen for KSHV antibodies
because stimulated BC3 cells provide the entire range of KSHV
antigens to detect anti-KSHV antibodies, and are more
sensitive than other KSHV serological assays. We believe that
the observed high seroprevalence, even though it is higher
than other reports, is speciﬁc because we titred the KSHV
antibodies by serial dilutions for all positive plasma samples.
We observed a wide range of titres, with some samples
showing speciﬁc ﬂuorescence at 10 000-fold plasma dilution.
Further, we also observed a high prevalence of neutralizing
antibodies in most caregivers and in some children, indicating
that the observed high seroprevalence in children and
caregivers is speciﬁc for KSHV. Our results also show that
GMT for KSHV was signiﬁcantly higher in caregivers as
compared with children though we did not observe any
relationship between age and KSHV titre. It is likely that these
caregivers have been infected for a longer time, resulting in
higher titres.
The neutralizing antibody response is known to play an
important role in preventing viral infection [29] and may be
protective against the development of KS [23]. Dilnur et al.
[11] have reported that Xinjiang province is an endemic area
for classic KS. We observed that the prevalence of neutralizing
TABLE 2. Univariate analysis of KSHV seroprevalence in the
study population
Socioeconomic status Odds ratio (95% CI) p-value
Total living area 1.00 (0.99–1.00) 0.28
Per capita living space 1.01 (0.98–1.05) 0.56
Number of rooms in house 0.87 (0.72–1.06) 0.17
Number of sleeping areas in house 1.08 (0.86–1.36) 0.50
Number of members in each
sleeping area
0.84 (0.62–1.14) 0.27
Temporary house vs. brick house (Ref) 0.73 (0.37–1.41) 0.34
No running water vs. running water (Ref) 0.79 (0.26–2.37) 0.67
Farmer vs. other (Ref) 0.61 (0.30–1.26) 0.19
Shared kitchen vs. private kitchen (Ref) 1.20 (0.48–2.99) 0.69
Ventilation in kitchen absent
vs. present (Ref)
1.09 (0.54–2.20) 0.81
Breastfeeding and eating practices
Premastication by caregiver* 0.82 (0.39–1.74) 0.61
Premastication by others* 0.92 (0.37–2.29) 0.86
Caregiver tests temperature of food* 0.77 (0.43–1.39) 0.39
Family tests temperature of food* 0.95 (0.51–1.77) 0.87
Others test temperature of food* 1.10 (0.46–2.59) 0.83
Caregiver cools food by blowing* 0.87 (0.48–1.57) 0.65
Others cool food by blowing* 0.83 (0.42–1.63) 0.58
Caregiver chews food for child* 0.98 (0.41–2.35) 0.96
Family chews food for child* 1.60 (0.58–4.41) 0.37
Others chew food for child* 1.38 (0.36–5.30) 0.64
Share food with family* 2.48 (1.36–4.54) 0.003
Share food with neighbours* 1.44 (0.61–3.41) 0.41
Exchange of food/candy among children* 1.20 (0.61–2.35) 0.60
Eat with hands from common bowl* 0.79 (0.43–1.46) 0.45
Caregiver shares tableware* 1.16 (0.58–2.34) 0.67
Others share tableware* 0.93 (0.43–2.01) 0.86
Caregiver shares packaged drinks* 0.82 (0.45–1.50) 0.51
Members share packaged drinks* 0.93 (0.49–1.79) 0.83
Others share packaged drinks* 0.62 (0.28–1.38) 0.24
Neighbours share packaged drinks* 0.81 (0.34–1.89) 0.62
Number of people who share,
1–3 vs. 4 or more (Ref)
0.82 (0.35–1.91) 0.64
Child spends night at
someone else’s house*
0.65 (0.20–2.06) 0.46
Share toothbrush* 1.34 (0.65–2.76) 0.43
Use paciﬁer vs. not use (Ref) 1.05 (0.58–1.90) 0.87
Share paciﬁer vs. not share (Ref) 0.85 (0.25–2.91) 0.80
Child being breastfed vs.
not breastfed (Ref)
1.12 (0.47–2.66) 0.79
Child being breastfed now vs.
not being breastfed (Ref)
0.82 (0.29–2.30) 0.70
Child eating solid food vs.
not eating (Ref)
0.74 (0.35–1.57) 0.43
Child hygiene and interactions
Ease teething pain with (Ref—No aid used)
Teething ring 0.81 (0.30–2.15) 0.67
Other 1.28 (0.63–2.61) 0.49
Bathing infrequently vs. at least
once or more/day (Ref)
1.36 (0.57–3.26) 0.49
Number of children who play with child (Ref—No children)
1–2 0.92 (0.31–2.74) 0.88
3–4 0.89 (0.30–2.64) 0.83
5 or more 0.66 (0.22–2.01) 0.46
Number of children who play with child (<5 years old) (Ref—No children)
1–2 1.24 (0.54–2.85) 0.62
3 to more 1.11 (0.49–2.52) 0.81
*Always/sometimes vs. infrequently/never categories were used as the reference
category.
TABLE 3. Multivariate logistic regression analysis of deter-
minants of KSHV seropositivity
Characteristic
Odds ratio
(95% conﬁdence interval) p-value
Gender of child 0.63 (0.33–1.20) 0.157
Ethnicity 5.38 (0.60–48.45) 0.133
Per capita living space 0.76 (0.40–1.45) 0.406
Occupation 0.64 0.30–1.39) 0.259
Number of rooms
in the house
0.85 (0.69–1.04) 0.105
Share food with
family members
2.19 (1.17–4.13) 0.015
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antibodies in KSHV-positive children (5.8%) was signiﬁcantly
lower as compared with KSHV-positive caregiver adults
(93.8%), with a median titre of 1:100 in caregivers. Taken
together, these results do not indicate that the high prevalence
of neutralizing antibodies in adults correlates with KS ende-
micity, but longitudinal studies are needed to investigate the
association between the presence of neutralizing antibodies
and the development of KS in this population.
A number of studies have documented that HIV-1 infection
is a signiﬁcant risk factor for KSHV infection [25,30].
However, we could not evaluate HIV-1 as a risk factor
because only two caregivers were found to be HIV-1 positive.
Interestingly, these results also suggest that in contrast to
other high HIV-1 and KSHV endemic regions, KSHV infection
in this population is independent of HIV both in adults and
children. Other potential risk factors may be involved and
need to be further investigated. This study has several
limitations. We could not evaluate KSHV DNA in saliva or
peripheral blood cells to determine viraemia as these samples
were not collected. Also, the cross-sectional design could not
examine when primary infection occurred or investigate the
risk factors that may be associated with KSHV incidence in
early childhood.
In summary, we observed that KSHV infection was highly
prevalent in early childhood in the Xinjiang region in China and
horizontal transmission appears to be the major route of
transmission through sharing food with family members.
Childhood infection appears to be the major contributing
factor to the high KSHV prevalence in the population. A better
understanding of the risk factors that are associated with
KSHV transmission to children would contribute to the design
and implementation of intervention strategies for prevention
of KSHV infection.
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